Fact Checked by Doctor NameWhat is Cannabicyclolic Acid (CBLA)?
Cannabicyclolic Acid (CBLA) is a rare compound commonly present in cannabis, known for its non-psychoactive properties.
In its pure form, it exists as cannabichromenic acid (CBCA), but environmental factors such as light exposure can convert it into cannabicyclolic acid.
Cannabicyclolic acid, although not naturally occurring, is synthetically produced through irradiation. It was first discovered in 1972 when Shoyama isolated its components, marking an important milestone in cannabinoid research.
Limited information is available about cannabicyclolic acid due to its low production in marijuana, which restricts our knowledge of this compound.
Cannabicyclolic acid, known for its stability when exposed to heat, does not undergo decarboxylation.
However, it’s unreactive nature and unfavourable experimental outcomes have led scientists to overlook this compound and its variants.
Due to the perception that studying it is time-consuming with minimal results, its potential remains to be explored in scientific research.
Cannabicyclolic acid is highly regarded in medicine due to its valuable therapeutic properties. Its anti-inflammatory and antitumor characteristics make it particularly desirable for individuals managing inflammation-related health conditions.
Moreover, it does not produce psychoactive effects in small doses, further enhancing its appeal for medical applications.
Cannabichromenate (CBCA) is derived from cannabigerol (CBGA) in cannabis plants. Under specific conditions, such as heating or over time, these cannabichromenates give rise to various cannabinoids, including CBC, CBL, and cannabicyclolic acid.
